Prosecution Insights
Last updated: April 19, 2026

Tega Therapeutics Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18064181 CELLULAR GLYCOSAMINOGLYCAN COMPOSITIONS AND METHODS OF MAKING AND USING FRONDA, CHRISTIAN L 1652 Non-Final OA Dec 09, 2022
17638760 HEPARIN AND HEPARAN SULFATE FROM MODIFIED MAST CELLS AND METHODS OF MAKING AND USING SABILA, MERCY HELLEN 1654 Final Rejection Feb 25, 2022

Managing Tega Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month